Acquired inhibitors to factors V and X after exposure to topical thrombin: Interference with monitoring of low molecular weight heparin and warfarin

Journal of Pediatrics

Volumn 131, Issue 3, 1997, Pages 480-483

  Israels, S J ^a   Leaker, M T ^a  

^a UNIVERSITY OF MANITOBA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 10; BLOOD CLOTTING FACTOR 5; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; THROMBIN; WARFARIN;

ANTIBODY DETECTION; ANTICOAGULATION; ARTICLE; BLOOD CLOTTING; CASE REPORT; FEMALE; HEART SURGERY; HEPARINIZATION; HUMAN; HUMAN CELL; HUMAN TISSUE; INTERFEROMETRY; POSTOPERATIVE HEMORRHAGE; PRESCHOOL CHILD; PRIORITY JOURNAL;

EID: 0030697160     PISSN: 00223476     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-3476(97)80084-4     Document Type: Article

References (20)

1. Green D Lechner K A survey of 215 non-hemophiliac patients with inhibitors to fac-tor VIII Thromb Haemost 45 1981 200 203
2. Stein J Ratnoff OD An inhibitor of anti-hemophiliac factor (factor VIII) in an 18-month-old non-hemophilic child Am J Pediatr Hematol Oncol 15 1993 346 350
3. Matsunaga AT Shafer FE An acquired in-hibitor to factor X in a pediatric patient with extensive burns J Pediatr Hematol Oncol 18 1996 223 226
4. Stricker RB Lane PK Lefert JD Rodgers GM Shuman MA Corash L Development of antithrombin antibodies following surgery in patients with prosthetic cardiac valves Blood 72 1988 1375 1380
5. Flaherty MJ Henderson R Wener MH Iatrogenic immunization with bovine thrombin: a mechanism for prolonged thrombin times in surgery Ann Intern Med 111 1989 631 634
6. Zehdner JL Leung LLK Development of antibodies to thrombin and factor V with recurrent bleeding in a patient exposed to topical bovine thrombin Blood 76 1990 2011 2016
7. Rapaport SI Zivelin A Minow RA Hunter CS Donnelly K Clinical significance of an-tibodies to bovine and human thrombin and factor V after surgical use of bovine throm-bin Am J Clin Pathol 97 1992 84 91
8. Banninger H Hardegger T Tobler A Barth A Schupbach P Reinhart W Fibrin glue in surgery: frequent development of in-hibitors of bovine thrombin and human fac-tor V Br J Haematol 85 1993 528 532
9. Cmolik BL Spero JA Magovern GJ Clark RE Redo cardiac surgery: late bleed-ing complications from topical thrombm-in-duced factor V deficiency J Thorac Cardiovasc Surg ,105 1993 222 228
10. Berruyer M Amiral J French P Belleville J Bastien O Clerc J Immunization by bovine thrombin used with fibrin glue during cardiovascular operations J Thorac Cardiovasc Surg 105 1993 892 897
11. Spero JA Bovine thrombin-induced in-hibitor of factor V and bleeding risk in post-operative neurosurgical patients J Neuro-surg 78 1993 817 820
12. Ortel TL Charles LA Keller FG Marcom PK Oldham HN Jr Kane WH Topical thrombin and acquired coagulation factor inhibitors: clinical spectrum and lab-oratory diagnosis Am J Hematol 45 1994 128 135
13. Israels SJ Israels ED Development of an-tibodies to bovine and human factor V in two children after exposure to topical bovine thrombin Am J Pediatr Hematol Oncol 16 1994 249 254
14. Muntean W Zenz W Finding K Zobel G Bietzke A Inhibitor to factor V after expo-sure to fibrin sealant during cardiac surgery in a two-year-old child Acta Pediatr 83 1994 84 87
15. Philadelphia: JB Lippincott White GC II Marder VJ Colman RW Hirsh J Salzman EW Approach to the bleeding patient Colman RW Hirsh J Marder VJ Salzman EW Hemostasis and thrombosis: basic principles and clinical practice 3rd ed. 1994 1134 1147
16. 271-177 Suzuki S Sakuragawa N A study on the properties of commercial thrombin prepa-rations Thromb Res 53 1989
17. Michelson AD Bovill E Andrew M Antithrombotic therapy in children Chest 108 1995 506S 522S
18. Massicotte P Adams M Marzinotto V Brooker LA Andrew M Low-molecular-weight heparm in pediatrie patients with thrombotic disease: a dose finding study J Pediatr 128 1996 313 318
19. Teien AN Lie M Evaluation of amidolytic heparin assay method: increased sensitivity by adding purified antithrombin III Thromb Res 10 1977 399 410
20. Jackson MR Tissue sealants: current status future potential Nature Med 2 1996 637 638